Gurnet Point Capital

Gurnet Point Capital Limited is private equity and venture capital firm.

Business Model: B2B

Revenue: $30M

Employees: 11-50

Rankings

Detailed Gurnet Point Capital Information

Geographic Data

Gurnet Point Capital headquarters map

Address: 55 Cambridge Pkwy Ste 401

City: Cambridge

State: MA

Zip: 02142

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

5,517,294Website Global Rank

1,544Website Monthly Traffic

Twitter Followers

Description

They partner with life science leaders who have the vision and drive to transform their businesses. Those leaders are born risk-takers. Original thinkers with big ideas and bigger ambitions. Explorers who question the status quo. They are driven to succeed and are uncompromising in their quest to make things happen, even if the solutions aren’t easy or obvious. They are leaders who know when they need a catalyst to achieve transformational growth. They seek a partner who shares their long-term vision and strengthens it with financial resources and commercial expertise, standing shoulder-to-shoulder with them for as long as it takes. One who speaks their language and has a history of building successful life science businesses in their own right. A like-minded team committed to helping them realize their vision.

Contact Phone:
+16175884900

Contact Email:

Announced Date Company Transaction Money Raised
11/2018 Axcella Series E 0
9/2022 Naveris Series A 33.4M
8/2021 Mahana Therapeutics Series B 0
12/2016 Auregen BioTherapeutics Venture Round -
10/2016 BEFORE Brands Series A 13.1M
3/2017 BEFORE Brands Series B 0
10/2022 Corium Private Equity Round -
5/2015 Axcella Series C 39M
6/2022 Alladapt Immunotherapeutics Venture Round 0
4/2020 Zikani Therapeutics Series A 0
12/2020 Tremeau Pharmaceuticals Private Equity Round -
4/2018 Zikani Therapeutics Venture Round 0
2/2020 Alladapt Immunotherapeutics Series C 0
12/2020 Naveris Series A -
12/2016 Crossover Health Venture Round 92M
5/2022 Fairtility Series A 0
6/2022 Alladapt Immunotherapeutics Venture Round 0
5/2022 Fairtility Series A 0
8/2021 Mahana Therapeutics Series B 0
12/2020 Naveris Series A -
12/2020 Tremeau Pharmaceuticals Private Equity Round -
4/2020 Zikani Therapeutics Series A 0
2/2020 Alladapt Immunotherapeutics Series C 0
11/2018 Axcella Series E 0
4/2018 Zikani Therapeutics Venture Round 0
3/2017 BEFORE Brands Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research